{
    "organizations": [],
    "uuid": "41936ff2107968342220b9481a597cbb4f7672e9",
    "author": "",
    "url": "https://www.reuters.com/article/brief-chemocentryx-secures-up-to-100-mil/brief-chemocentryx-secures-up-to-100-million-in-new-capital-commitments-idUSFWN1OZ0MG",
    "ord_in_thread": 0,
    "title": "BRIEF-Chemocentryx Secures Up To $100 Million In New Capital Commitments",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 4, 2018 / 12:24 PM / in 9 minutes BRIEF-Chemocentryx Secures Up To $100 Million In New Capital Commitments Reuters Staff \nJan 4 (Reuters) - Chemocentryx Inc: \n* CHEMOCENTRYX SECURES UP TO $100 MILLION IN NEW CAPITAL COMMITMENTS \n* CHEMOCENTRYX INC SAYS WILL RECEIVE $50 MILLION MILESTONE PAYMENT FROM VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA \n* CHEMOCENTRYX INC - CO ALSO ENTERS INTO $50 MILLION GROWTH CAPITAL FINANCING AGREEMENT WITH HERCULES CAPITAL \n* CHEMOCENTRYX INC SAYS ALSO ENTERS INTO $50 MILLION GROWTH CAPITAL FINANCING AGREEMENT WITH HERCULES CAPITAL \n* CHEMOCENTRYX - ‍ADDITIONAL CAPITAL TO PROVIDE FUNDING TO ADVANCE AVACOPAN THROUGH TOPLINE DATA FROM PHASE III ADVOCATE TRIAL \n* CHEMOCENTRYX INC - ADDITIONAL CAPITAL ALSO EXPECTED TO PROVIDE FUNDING​ FOR‍ POTENTIAL REGISTRATION FILINGS IN U.S. AND EU. Source text for Eikon: Further company coverage:",
    "published": "2018-01-04T14:24:00.000+02:00",
    "crawled": "2018-01-04T14:36:05.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "minute",
        "secures",
        "million",
        "new",
        "capital",
        "commitment",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "chemocentryx",
        "inc",
        "chemocentryx",
        "secures",
        "million",
        "new",
        "capital",
        "commitment",
        "chemocentryx",
        "inc",
        "say",
        "receive",
        "million",
        "milestone",
        "payment",
        "vifor",
        "fresenius",
        "medical",
        "care",
        "renal",
        "pharma",
        "chemocentryx",
        "inc",
        "co",
        "also",
        "enters",
        "million",
        "growth",
        "capital",
        "financing",
        "agreement",
        "hercules",
        "capital",
        "chemocentryx",
        "inc",
        "say",
        "also",
        "enters",
        "million",
        "growth",
        "capital",
        "financing",
        "agreement",
        "hercules",
        "capital",
        "chemocentryx",
        "capital",
        "provide",
        "funding",
        "advance",
        "avacopan",
        "topline",
        "data",
        "phase",
        "iii",
        "advocate",
        "trial",
        "chemocentryx",
        "inc",
        "additional",
        "capital",
        "also",
        "expected",
        "provide",
        "potential",
        "registration",
        "filing",
        "eu",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}